Evidence map›Paper›PMID 31919372›Full record

ArticleScientific reports2020

Structure-activity relationship studies of four novel 4-aminopyridine K

Sofia Rodríguez-Rangel, Alyssa D Bravin, Karla M Ramos-Torres, Pedro Brugarolas, Jorge E Sánchez-Rodríguez

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Potassium rhythms couple the circadian clock to the cell cycle.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Metabolic Stability of the Demyelination Positron Emission Tomography Tracer [The Journal of pharmacology and experimental therapeutics · 2023
    Article
  13. Radiochemical Synthesis and Evaluation of 3-[ACS chemical neuroscience · 2022
    Article
  14. Review
  15. A NovelInternational journal of molecular sciences · 2021
    Article
  16. Evaluation of the potassium channel tracer [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  17. Article
  18. Neuroprotective Properties of 4-Aminopyridine.Neurology(R) neuroimmunology & neuroinflammation · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sofia Rodríguez-RangelDepartamento de Física, Universidad de Guadalajara, Guadalajara, Jalisco, 44430, Mexico.
Alyssa D BravinGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Karla M Ramos-TorresGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA.
Pedro BrugarolasGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. pbrugarolas@mgh.harvard.edu.
Jorge E Sánchez-RodríguezDepartamento de Física, Universidad de Guadalajara, Guadalajara, Jalisco, 44430, Mexico. jorge.srodriguez@academicos.udg.mx.

Funding

Unified Joint Statistical Reconstruction of PET & MRP41EB022544 · NIBIB · YALE UNIVERSITY · PI Georges El Fakhri · 2017 to 2026
$14.8M
Postgraduate Training Program in Medical Imaging (PTPMI)T32EB013180 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Ciprian Catana, Pedram Heidari · 2011 to 2026
$3.7M
Can [18F]3F4AP Detect Brain Demyelination? Evaluation of Novel PET Tracer in Nonhuman Primates and HumansR01NS114066 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BRUGAROLAS, PEDRO · 2020 to 2024
$1.8M
New tools for imaging: diagnostics based on therapeuticsR00EB020075 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI BRUGAROLAS, PEDRO · 2017 to 2019
$747k
NIBIB NIH HHS P41 EB022544NIBIB NIH HHS R00 EB020075NIBIB NIH HHS T32 EB013180NINDS NIH HHS R01 NS114066
6 · The paper itself

Abstract

4-Aminopyridine (4AP) is a specific blocker of voltage-gated potassium channels (K

Indexed as

4-AminopyridineAction PotentialsAnimalsDrosophilaDrosophila ProteinsHydrogen-Ion ConcentrationKineticsOocytesPotassium Channel BlockersPotassium Channels, Voltage-GatedStructure-Activity RelationshipXenopus laevis4-AminopyridineDrosophila ProteinsPotassium Channel BlockersPotassium Channels, Voltage-Gated

Identifiers

PMID31919372
PMCPMC6952366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.